News

2008-11-21 Polish biotechnologists and new therapeutics based on coffee compounds

Trigendo Limited company is innovative privately founded Polish biotech company, researching chemical compounds found in coffee that can be used as potential drugs. The company's main focus is on chemical, biochemical and pharmacological research leading to development of new drugs which can bring therapeutic effects in diseases associated with endothelial dysfunction.

In results, it may lead to treatment or prevention of many diseases of civilization, e.g.: liver injuries, diabetes tyope 2, atherosclerosis, kidney degeneration and obesity.

Other company's activities include conducting research on functional food and food suplements that can beneficial when treating diseases caused by endothelial dysfunction.

Another field of research is preparing formulas and technology of production dermatologic drugs and cosmeceutics affecting skin diseases and inflammations, as well wound healing.

Intellectual property of the company consist of unique know-how about active compounds found in coffee researched by founders and technology of production of food and cosmetics containing those compounds.

Trigendo Ltd.'s intellectual property is protected by patent claims filled in Poland, USA and other international markets (following Patent Cooperation Treaty procedure).

Izabela Klockowska